CIK 0001070494
- Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061376651
- Phone
- +1 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale Director sold 60,000 shares at $25.03 ($1,501,752)
- 4 Open-market sale EXEC VP, CFO AND CBO sold 30,000 shares at $24.88 ($746,334)
- 4 Option exercise CEO acquired 6,500 shares (option exercise)
- 4 Option exercise EXEC VP, CFO AND CBO acquired 12,000 shares (option exercise)
- 4 Open-market sale Director sold 44,117 shares at $23.41 ($1,032,911)
- 4 Open-market sale CEO sold 15,000 shares at $23.45 ($351,807)
- 4 Open-market sale Director sold 37,692 shares at $23.00 ($867,033)
- 4 Open-market sale CEO sold 15,000 shares at $23.24 ($348,638)
- 4 Open-market sale Director sold 10,000 shares at $21.63 ($216,256)
- 4 Open-market sale EXEC VP, CFO AND CBO sold 30,000 shares at $27.87 ($836,121)
- 4 Open-market sale EVP, DEVELOPMENT AND CMO sold 35,965 shares at $25.01 ($899,312)
- 4 Open-market sale Director sold 60,000 shares at $22.92 ($1,375,470)
- 4 Open-market sale Director sold 66,356 shares at $22.90 ($1,519,672)
- 4 Open-market sale Director sold 46,153 shares at $22.80 ($1,052,145)
- 4 Open-market sale Director sold 40,000 shares at $20.28 ($811,100)
- 4 Open-market sale Director sold 15,000 shares at an average $20.68 ($310,211)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CEO sold 52,771 shares at $20.14 ($1,063,061)
- 4 Open-market sale EXEC VP, CFO AND CBO sold 60,000 shares at $20.15 ($1,209,180)
Page 23 of 35 · 686 filings